Sarcopenia means loss of skeletal muscle mass or loss of flesh by aging. Sarcopenia is associated with functional impairments in tasks such as standing up from a chair or lifting 10 pounds and physical disabilities such as not able to perform home chores and personal care. The loss of muscle tissue may progress more rapidly after the age of 60 or 70, however the exact rate of decline may vary, and a person may lose 3-8% of muscle mass per decade. Symptoms of Sarcopenia include decrease in muscle size, weakness, loss of endurance, trouble in climbing stairs and poor balance. As such there is no approved treatment available for sarcopenia, however nutrition and dietary supplements can play an important role in its treatment. Nutrition prevents accelerated muscle loss during the period of muscle disuse and maintains energy levels. Some of the important supplements for treating sarcopenia include proteins, amino acids, creatine, omega 3 acid, vitamin D and B12, and calcium carbonate.
Sarcopenia Treatment Market Drivers
Increasing geriatric population is expected to boost growth of the sarcopenia treatment market growth. According to the World Health Organization, by 2050, the world’s population aged 60 years and above is expected reach 2 billion from 900 million in 2015. The conferences, meetings held by the foundations help to expand and share the knowledge and information about the sarcopenia treatment which will in turn drives the growth of sarcopenia treatment market. For instance, in April 2017, the U.S. Food and Drug Administration (FDA) held its public meeting on Patient Focused Drug Development (PFDD) for sarcopenia. The focus of the meeting was to obtain patient perspectives on symptoms and daily impacts of their condition.
Increasing investments in production of drugs and supplements are expected to boost growth of the sarcopenia treatment market. Furthermore, a growing number of pharmaceutical and food processing companies are focused on developing nutrition supplements for treatment of sarcopenia. For instance, in February 2016, Nestle announced that it has made a strategic investment for of USD 42.5 million in Pronutria Biosciences. The Nestlé’s cash will used by Pronutria Biosciences to develop a new compound called PN-107, which has the potential to tackle muscle loss caused by aging, prolonged bed rest. These factors are expected to drive growth of the sarcopenia treatment market.
Malnutrition and vitamin deficiency in developing countries is expected to boost growth of the sarcopenia treatment market. Reduction of hormone secretion rate and increasing vitamin deficiency as a result of aging are expected to create high demand for sarcopenia treatment supplements. Economic factors such as rise in consumer spending by the geriatric population, and increasing per capita healthcare expenditure are expected to drive demand for sarcopenia treatment supplements. According to the National Health Expenditure Accounts (NHEA), in 2016 the U.S. health care spending grew by 4.3%, reaching US$ 3.3 trillion or US$ 10,348 per person.
However, no new developments for the treatment of sarcopenia are also expected to hamper the market growth of sarcopenia treatment. In addition, the non-availability of new drugs is expected to hinder the sarcopenia treatment market in the upcoming years.
Sarcopenia Treatment Market Regional Analysis
North America is expected to hold a dominant position in the sarcopenia treatment market, owing to presence of developed healthcare facilities and infrastructure in countries such as the U.S, and Canada. Moreover, the demand for sarcopenia treatment has increased in the region due to high focus on healthcare by the government, technological advancements are likely to fuel growth of the sarcopenia treatment market during the forecast period.
Europe is expected to be the second largest sarcopenia treatment market over the forecast period. For instance, in February 2019, Biophytis SA, a Paris (France) based company focused on development of novel therapeutics for age-related diseases, announced three oral and poster presentations at the 2019 International Conference on Frailty and Sarcopenia Research (ICFSR). In this conference, the company presented the details of its lead clinical drug candidate, Sarconeos (BIO 101), that included its history and unique mechanism that targets the MAS receptor for preservation of muscle function in muscle wasting disorder. In addition, the company also presented the clinical trial design of its ongoing SARA Phase 2 study of Sarconeos to treat sarcopenia.
Sarcopenia Treatment Market Key Players
Some of the major players operating in the sarcopenia treatment market include GlaxoSmithKline, Radius Health Inc., Five Prime Therapeutics, Inc., Abbott Laboratories, Pfizer Inc., Nestle S.A., Sanofi S.A., Bayer AG, and Novartis AG, Cadila Healthcare Ltd.
Sarcopenia Treatment Market Taxonomy
On the basis of treatment type, the global sarcopenia treatment market is segmented into:
On the basis of distribution channel, the global sarcopenia treatment market is segmented into:
On the basis of region, the global sarcopenia treatment market is segmented into:
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.